Cargando...
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Imipenem/cilastatin/relebactam (Recarbrio™) is an intravenously administered combination of the carbapenem imipenem, the renal dehydropeptidase-I inhibitor cilastatin, and the novel β-lactamase inhibitor relebactam. Relebactam is a potent inhibitor of class A and class C β-lactamases, conferring imi...
Gardado en:
| Publicado en: | Drugs |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7905759/ https://ncbi.nlm.nih.gov/pubmed/33630278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01471-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|